CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 199 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,239,000 | -54.6% | 6,261,903 | +3.5% | 0.00% | – |
Q3 2018 | $2,728,000 | -3.7% | 6,047,564 | +7.5% | 0.00% | – |
Q2 2018 | $2,833,000 | -79.8% | 5,625,864 | -6.4% | 0.00% | -100.0% |
Q1 2018 | $13,999,000 | -42.3% | 6,007,985 | -29.6% | 0.00% | 0.0% |
Q4 2017 | $24,248,000 | +10.5% | 8,538,175 | +11.3% | 0.00% | 0.0% |
Q3 2017 | $21,941,000 | -9.1% | 7,671,589 | -21.5% | 0.00% | 0.0% |
Q2 2017 | $24,143,000 | -26.2% | 9,774,858 | +7.8% | 0.00% | -50.0% |
Q1 2017 | $32,731,000 | +18.7% | 9,066,763 | +16.4% | 0.00% | 0.0% |
Q4 2016 | $27,571,000 | -8.9% | 7,788,557 | +4.0% | 0.00% | 0.0% |
Q3 2016 | $30,252,000 | -5.1% | 7,487,884 | +3.1% | 0.00% | 0.0% |
Q2 2016 | $31,886,000 | +24.6% | 7,263,339 | +7.3% | 0.00% | 0.0% |
Q1 2016 | $25,595,000 | -76.0% | 6,771,237 | -0.3% | 0.00% | -71.4% |
Q4 2015 | $106,488,000 | -77.4% | 6,791,275 | -69.3% | 0.01% | -61.1% |
Q3 2015 | $470,584,000 | +193.4% | 22,140,820 | +248.2% | 0.02% | +63.6% |
Q2 2015 | $160,368,000 | -5.5% | 6,358,746 | +4.4% | 0.01% | -8.3% |
Q1 2015 | $169,744,000 | +72.1% | 6,090,594 | +12.7% | 0.01% | +71.4% |
Q4 2014 | $98,648,000 | +46.3% | 5,405,353 | +3.9% | 0.01% | +40.0% |
Q3 2014 | $67,417,000 | -20.2% | 5,201,935 | +0.4% | 0.01% | -28.6% |
Q2 2014 | $84,531,000 | -5.9% | 5,179,569 | +1.9% | 0.01% | -12.5% |
Q1 2014 | $89,818,000 | -25.4% | 5,083,094 | +2.2% | 0.01% | -27.3% |
Q4 2013 | $120,379,000 | -11.0% | 4,972,275 | +30.2% | 0.01% | -15.4% |
Q3 2013 | $135,318,000 | +244.3% | 3,819,298 | +51.7% | 0.01% | +225.0% |
Q2 2013 | $39,304,000 | – | 2,517,906 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Byrne Asset Management LLC | 86 | $2,000 | 0.00% |